A detailed history of Alliancebernstein L.P. transactions in Johnson & Johnson stock. As of the latest transaction made, Alliancebernstein L.P. holds 4,714,523 shares of JNJ stock, worth $761 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
4,714,523
Previous 5,198,585 9.31%
Holding current value
$761 Million
Previous $822 Million 16.21%
% of portfolio
0.25%
Previous 0.3%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$144.38 - $157.78 $69.9 Million - $76.4 Million
-484,062 Reduced 9.31%
4,714,523 $689 Million
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $53 Million - $55.6 Million
-341,442 Reduced 6.16%
5,198,585 $822 Million
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $65.3 Million - $71.3 Million
-448,814 Reduced 7.49%
5,540,027 $868 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $186 Million - $208 Million
-1,194,798 Reduced 16.63%
5,988,841 $933 Million
Q2 2023

Aug 15, 2023

SELL
$154.35 - $166.11 $150 Million - $161 Million
-971,552 Reduced 11.91%
7,183,639 $1.19 Billion
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $53.1 Million - $63.4 Million
351,509 Added 4.5%
8,155,191 $1.26 Billion
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $116 Million - $130 Million
722,090 Added 10.2%
7,803,682 $1.38 Billion
Q3 2022

Nov 15, 2022

SELL
$161.33 - $179.52 $54.6 Million - $60.8 Million
-338,515 Reduced 4.56%
7,081,592 $1.16 Billion
Q2 2022

Aug 15, 2022

BUY
$168.19 - $186.01 $80 Million - $88.5 Million
475,622 Added 6.85%
7,420,107 $1.32 Billion
Q1 2022

May 13, 2022

BUY
$158.14 - $179.59 $2.47 Million - $2.81 Million
15,643 Added 0.23%
6,944,485 $1.23 Billion
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $46.7 Million - $51.8 Million
299,395 Added 4.52%
6,928,842 $1.19 Billion
Q3 2021

Nov 10, 2021

BUY
$161.5 - $179.47 $13.5 Million - $15 Million
83,306 Added 1.27%
6,629,447 $1.07 Billion
Q2 2021

Jul 30, 2021

SELL
$159.48 - $171.07 $13.8 Million - $14.8 Million
-86,786 Reduced 1.31%
6,546,141 $1.08 Billion
Q1 2021

May 06, 2021

SELL
$153.07 - $170.48 $282 Million - $314 Million
-1,843,726 Reduced 21.75%
6,632,927 $1.09 Billion
Q4 2020

Feb 08, 2021

SELL
$137.11 - $157.38 $265 Million - $305 Million
-1,935,669 Reduced 18.59%
8,476,653 $1.33 Billion
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $7.05 Million - $7.72 Million
50,203 Added 0.48%
10,412,322 $1.55 Billion
Q2 2020

Aug 13, 2020

SELL
$128.81 - $155.51 $58.7 Million - $70.9 Million
-455,783 Reduced 4.21%
10,362,119 $1.46 Billion
Q1 2020

May 14, 2020

BUY
$111.14 - $153.99 $158 Million - $218 Million
1,418,577 Added 15.09%
10,817,902 $1.42 Billion
Q4 2019

Feb 18, 2020

BUY
$127.5 - $146.44 $204 Million - $234 Million
1,599,581 Added 20.51%
9,399,325 $1.37 Billion
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $19.8 Million - $22.2 Million
156,165 Added 2.04%
7,799,744 $1.01 Billion
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $123 Million - $136 Million
939,565 Added 14.01%
7,643,579 $1.06 Billion
Q1 2019

May 14, 2019

SELL
$125.72 - $139.79 $40.1 Million - $44.5 Million
-318,573 Reduced 4.54%
6,704,014 $937 Million
Q4 2018

Feb 13, 2019

SELL
$122.84 - $147.84 $20.4 Million - $24.6 Million
-166,317 Reduced 2.31%
7,022,587 $906 Million
Q3 2018

Nov 08, 2018

BUY
$121.58 - $142.88 $40.4 Million - $47.5 Million
332,417 Added 4.85%
7,188,904 $993 Million
Q2 2018

Aug 13, 2018

SELL
$119.4 - $131.76 $232 Million - $256 Million
-1,942,222 Reduced 22.07%
6,856,487 $832 Million
Q1 2018

May 14, 2018

SELL
$125.1 - $148.14 $114 Million - $135 Million
-914,103 Reduced 9.41%
8,798,709 $1.13 Billion
Q4 2017

Feb 13, 2018

SELL
$131.22 - $143.62 $79.9 Million - $87.5 Million
-609,172 Reduced 5.9%
9,712,812 $1.36 Billion
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $1.34 Billion - $1.4 Billion
10,321,984
10,321,984 $1.34 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $422B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.